These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21118937)

  • 21. [Miltefosine: a new remedy for leishmaniasis].
    Dorlo TP; Eggelte TA; Beijnen JH; de Vries PJ
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2697-701. PubMed ID: 17194005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcome of imported cutaneous leishmaniasis among travelers and migrants infected with Leishmania major and Leishmania tropica: a retrospective study in European centers 2013 to 2019.
    Glans H; Dotevall L; Van der Auwera G; Bart A; Blum J; Buffet P; Guery R; Gangneux JP; van Henten S; Harms G; Varani S; Robert-Gangneux F; Rongisch R; Andersson B; Bradley M
    Int J Infect Dis; 2022 Sep; 122():375-381. PubMed ID: 35728749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes.
    Nazari-Vanani R; Vais RD; Sharifi F; Sattarahmady N; Karimian K; Motazedian MH; Heli H
    Acta Trop; 2018 Sep; 185():69-76. PubMed ID: 29733808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosine.
    Poeppl W; Walochnik J; Pustelnik T; Auer H; Mooseder G
    Am J Trop Med Hyg; 2011 Apr; 84(4):562-5. PubMed ID: 21460010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
    Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
    Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
    Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
    van Henten S; Tesfaye AB; Abdela SG; Tilahun F; Fikre H; Buyze J; Kassa M; Cnops L; Pareyn M; Mohammed R; Vogt F; Diro E; van Griensven J
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009460. PubMed ID: 34048461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral miltefosine to treat new world cutaneous leishmaniasis.
    Soto J; Toledo JT
    Lancet Infect Dis; 2007 Jan; 7(1):7. PubMed ID: 17182338
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of a married couple for American leishmaniasis with miltefosine.
    Wöhrl S; Schnedl J; Auer H; Walochnik J; Stingl G; Geusau A
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):258-9. PubMed ID: 18211436
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis.
    Ramesh V; Dixit KK; Sharma N; Singh R; Salotra P
    J Infect Dis; 2020 Feb; 221(4):608-617. PubMed ID: 31854451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced case of PKDL due to delayed treatment: A rare case report.
    Topno RK; Rabi Das VN; Kumar M; Madhukar M; Pandey K; Verma N; Agrawal K; Lal CS; Siddiqui NA; Bimal S; Das P
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008052. PubMed ID: 32203500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous leishmaniasis successfully treated with miltefosine.
    Chan CX; Simmons BJ; Call JE; Yan S; Glass JS; Chapman MS
    Cutis; 2020 Oct; 106(4):206-209. PubMed ID: 33186422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Apigenin and Miltefosine Combination Therapy against Experimental Cutaneous Leishmaniasis.
    Emiliano YSS; Almeida-Amaral EE
    J Nat Prod; 2018 Aug; 81(8):1910-1913. PubMed ID: 30095915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl.
    Hamzavi SS; Sanaei Dashti A; Kadivar MR; Pouladfar G; Pourabbas B
    Pediatr Infect Dis J; 2018 Mar; 37(3):275-277. PubMed ID: 29424815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inadequacy of 12-Week Miltefosine Treatment for Indian Post-Kala-Azar Dermal Leishmaniasis.
    Ghosh S; Das NK; Mukherjee S; Mukhopadhyay D; Barbhuiya JN; Hazra A; Chatterjee M
    Am J Trop Med Hyg; 2015 Oct; 93(4):767-9. PubMed ID: 26175030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
    Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Miltefosine in cutaneous leishmaniasis.
    Rahman SB; ul Bari A; Mumtaz N
    J Coll Physicians Surg Pak; 2007 Mar; 17(3):132-5. PubMed ID: 17374296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for American cutaneous and mucocutaneous leishmaniasis.
    Pinart M; Rueda JR; Romero GA; Pinzón-Flórez CE; Osorio-Arango K; Silveira Maia-Elkhoury AN; Reveiz L; Elias VM; Tweed JA
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004834. PubMed ID: 32853410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.
    Castro MDM; Cossio A; Velasco C; Osorio L
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005515. PubMed ID: 28379954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.